Skip to main content
. 2022 Mar 30;5(3):e225032. doi: 10.1001/jamanetworkopen.2022.5032

Table. Baseline Demographic Characteristics of Participants Included in Subset Analysis.

Characteristic Participants, No. (%)
Estradiol + placebo gel (n = 45) Moisturizer + placebo tablet (n = 48) Dual placebo (n = 51)
Age at screening, mean (SD), y 61 (4) 60 (4) 61 (5)
Race
Black 5 (11) 1 (2) 0 (0)
White 37 (82) 43 (90) 49 (96)
Othera 3 (7) 4 (8) 2 (4)
MBS
Pain with sex 19 (42) 32 (67) 28 (55)
Dryness 11 (24) 8 (17) 14 (27)
Itch, burn, or irritation 15 (33) 8 (17) 9 (18)
Vaginal maturation index, <5% superficial cells 37 (82) 37 (77) 40 (78)
pH, mean (SD) 6.8 (1.0) 6.6 (1.1) 6.9 (0.9)
Subsequent MBS symptom improvement ≥2 points 24 (53) 21 (44) 25 (49)

Abbreviation: MBS, most bothersome symptom.

a

Other race includes 2 American Indian individuals, 6 Asian or Pacific Islander individuals, and 1 unknown individual with unknown race.